1377567-47-9

Basic information

• Product Name: (2-amino-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)(p-tolyl)methanone
• Synonyms: (2-amino-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)(p-tolyl)methanone
• CAS NO: 1377567-47-9
• Molecular Weight: 255.319
• Mol File: 1377567-47-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2-amino-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)(p-tolyl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (2-amino-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)(p-tolyl)methanone(1377567-47-9)
• EPA Substance Registry System: (2-amino-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)(p-tolyl)methanone(1377567-47-9)

Safety Data

• Hazardous Substances Data: 1377567-47-9(Hazardous Substances Data)

Upstream product

• 5693-62-9 2,3,4,5-tetrahydro-6-methoxypyridine 
• 97482-06-9 N-(piperidin-2-ylidene)cyanamide 
• 1377567-46-8 N-(1-(2-oxo-2-p-tolylethyl)piperidin-2-ylidene)cyanamide 

Downstream Products

• 1377567-48-0 ethyl 2-(2-methyl-4-p-tolyl-5,6,7,8-tetrahydropyridino[1,2-b]imidazo[4,5-b]pyridin-3-yl)pentanoate 
• 1377565-43-9 2-(2-methyl-4-p-tolyl-5,6,7,8-tetrahydropyridino[1,2-b]imidazo[4,5-b]pyridin-3-yl)pentanoic acid 

Relevant articles and documents

Novel Antiviral Compounds

The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.